Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology
Taoyuan, Taiwan
Hospital in Taoyuan City
No. 5, Fuxing St, Guishan District, Taoyuan City, 333
About Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology
The Linkou Chang Gung Memorial Hospital also known as Chang Gung Memorial Hospital or "Chang Gung Hospital", is a hospital located in Guishan District, Taoyuan City, Taiwan. It is part of the Chang Gung Medical Foundation hospital network.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Genentech, Inc.
1
Clinical Trials at Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology
During the past decade, Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
2011-07-26
2018-01-31
Terminated
1,418
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
2011-07-06
2021-07-30
Completed
1,401
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
2012-09-03
2016-04-30
Terminated
415
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
2013-06-10
2019-12-31
Completed
780
A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
2013-08-14
2021-01-26
Completed
153
A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy
2014-03-11
2019-01-09
Completed
1,225
A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
2021-02-23
2025-04-15
Recruiting
270
A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide in Patients With Follicular Lymphoma After at Least One Line of Systemic Therapy
2021-10-27
2029-05-01
Recruiting
400
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology"
#1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology
According to Clinical.Site data, the most researched conditions in "Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology" are
"Gastric Cancer" (3 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology
Most popular intervention types in "Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Obinutuzumab" (3 trials), "Rituximab" (3 trials), "5-Fluorouracil" (2 trials), "Cyclophosphamide" (2 trials) and "Doxorubicin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology
The vast majority of trials in "Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology" are
8 trials for "All" genders.
Clinical Trials Status at Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology
Currently, there are NaN active trials in "Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Chang Gung Medical Foundation - Linkou; Division of Hematology- Oncology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".